Top Markets
#1 Islamic Coin Islamic Coin +152.24%
#2 Bitway Bitway +39.12%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.70%
#4 aelf aelf +32.50%
#5 Starpower Starpower +24.83%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.32%
#7 Pons Pons +22.88%
#8 Decred Decred +14.71%
#9 DAPPOS DAPPOS +11.21%
#10 Talus Network Talus Network +10.95%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Rang in aandelen #30194
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Aandeelprijs
$0.21877731
Marktkapitalisatie
$17.53M
Verandering (1 dag)
-1.57%
Verandering (1 jaar)
-16.15%
Land
TW
Handel TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Categorie

Healthcare
Winst voor TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van TaiwanJ Pharmaceuticals Co., Ltd. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van TaiwanJ Pharmaceuticals Co., Ltd. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR